Lazard Asset Management’s St Jude Medical STJ Stock Holding History

Lazard Asset Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,633	Closed	-$211K	–	1113
2016 Q4	$211K	Buy	+2,633	New	+$209K	﹤0.01%	787
2015 Q4	–	Sell	-4,243	Closed	-$267K	–	1182
2015 Q3	$267K	Buy	+4,243	New	+$303K	﹤0.01%	752
2015 Q2	–	Sell	-24	Closed	-$1K	–	1218
2015 Q1	$1K	Buy	+24	New	+$1.6K	﹤0.01%	1110
2014 Q2	–	Sell	-39,337	Closed	-$2.57M	–	1092
2014 Q1	$2.57M	Buy	+39,337	New	+$2.56M	0.01%	565

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Lazard Asset Management's STJ Position: Q1 2017 in Review

Lazard Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,633 shares — an estimated $211K sold.

Lazard Asset Management first reported a position in STJ in Q1 2014 and held it in 4 quarters. The position peaked at $2.57M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Lazard Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Lazard Asset Management sold 2,633 St Jude Medical shares in Q1 2017, an estimated $211K.
Lazard Asset Management first reported a position in St Jude Medical in Q1 2014 and held it in 4 quarters.
Lazard Asset Management's St Jude Medical position peaked at $2.57M in Q1 2014.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Lazard Asset Management's 13F filing for Q1 2017, filed 12 May 2017.